iRadimed(IRMD) - 2025 Q3 - Quarterly Results
Exhibit 99.1 IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results Announces Regular Quarterly Cash Dividend of $0.17 Per Share and Raises Full-Year Guidance Orlando, Florida, November 3, 2025 – IRADIMED CORPORATION (the "Company" or "Iradimed") (NASDAQ: IRMD) announced today its financial results for the three and nine months ended September 30, 2025. The Company is a leader in developing innovative magnetic resonance imaging ("MRI") compatible medical devices and products. The Company i ...